Form 4: BioLargo Director Linda Park Receives Option Grant for Board Service
SEC Form 4
Director Linda Park received an option to purchase 73,529 shares of BioLargo stock as compensation for board service.
Summary
- Linda Park, a director of BioLargo, Inc. (BLGO), received an option to purchase 73,529 shares of common stock at an exercise price of $0.255 on June 30, 2024.
- The option was granted as payment for $18,750 in fees for board services during the most recent quarterly period, according to the company's 2024 Equity Incentive Plan.
- Following the transaction, Park directly owns options to purchase 712,811 shares of BioLargo common stock.
- John R. Browning, acting as attorney-in-fact, signed the Form 4 on July 1, 2024.
- A Limited Power of Attorney was executed on November 1, 2022, granting John R. Browning the authority to file Section 16 reports on behalf of Linda Park.
Sentiment
Score: 6
Explanation: The document is a routine regulatory filing related to director compensation. It is neutral in tone and does not contain any information that would significantly impact investor sentiment.
Positives
- The option grant aligns the director's interests with those of shareholders.
- The use of equity as compensation can conserve cash for the company.
Future Outlook
The document does not contain any specific forward-looking statements or guidance.
Industry Context
Option grants to directors are a common practice in publicly traded companies to align their interests with those of shareholders and incentivize performance. The size and terms of the grant are typical for a company of BioLargo's size and stage.
Comparison to Industry Standards
- Comparing BioLargo's director compensation practices to similar small-cap companies in the environmental technology sector, the use of options is a standard practice.
- Companies like OriginClear and Aqua Metals also utilize equity-based compensation for their board members.
- The specific value of the option grant would need to be benchmarked against peer companies to determine if it is above or below average.
Stakeholder Impact
- Shareholders may view the option grant as a positive sign that the director's interests are aligned with theirs.
- Employees may see the use of equity compensation as a sign of the company's commitment to long-term growth.
Key Dates
| Date | Description |
|---|---|
| 2022-11-01 | Limited Power of Attorney executed, granting John R. Browning authority to file Section 16 reports on behalf of Linda Park. |
| 2024-06-30 | Date of the option grant to Linda Park. |
| 2024-06-30 | Option exercisable date. |
| 2024-06-30 | Option Expiration Date. |
| 2024-07-01 | Date of Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.